Lemtrada
Lemtrada
Lemtrada is an infusion therapy that is indicated to treat relapsing forms of multiple sclerosis (MS) in adults who have tried two or more other MS medications that haven’t worked well enough.
Administration Information
Lemtrada infusions are administered in eight doses over two years, on five consecutive days in round one and, one year later, on three consecutive days in round two. Each infusion takes approximately four hours with a two hour observation period afterwards.
Potential Side Effects
Lemtrada can cause serious side effects, including autoimmune problems, infusion reactions, stroke and tears in your arteries that supply blood to your brain (carotid and vertebral arteries), and certain cancers. Because of your risk of autoimmunity, infusion reactions, and the risk of some kinds of cancers, Lemtrada is only available through a restricted program called the Lemtrada Risk Evaluation and Mitigation Strategy (REMS) Program.
For a full list of potential side effects, please see the Important Safety Information and Medication Guide on the Lemtrada website.
Helpful Resources
LEMTRADA WEBSITE
WHY LEMTRADA
LEMTRADA PATIENT STORIES
RESOURCES AND SUPPORT
Before you attend your first appointment at Sage Infusion, please make sure to review the documents below. The Patient Consent Form and HIPAA Privacy Authorization Form need to be filled out and signed ahead of your appointment, whereas the Notice of Privacy Practices and Patient Rights and Responsibilities are for reference only. Please contact us if you have any questions!
Patient Consent Form
HIPAA Privacy Authorization Form
Notice of Privacy Practices
Patient Rights and Responsibilities
Find a Sage Infusion Location Near You
We offer expert infusion therapy without the hassle or cost of the hospital. We employ highly trained medical staff that work with health insurance companies & physicians to provide our patients with convenient care.
SEARCH BY ZIP
Tampa See Location
Clearwater See Location
Sarasota See Location
Orlando See Location
Ft. Myers Coming Soon!